Kojima Y, Suzuki S, Sakaguchi T, Tsuchiya Y, Okamoto K, Kurachi K, Okumura T, Igarashi T, Takehara Y, Nakamura S
Department of Surgery II, Hamamatsu University School of Medicine, Japan.
Surg Today. 2000;30(9):844-8. doi: 10.1007/s005950070071.
Microwave coagulation therapy (MCT) is one of the treatment modalities for patients with hepatocellular carcinoma (HCC). A 67-year-old man with liver cirrhosis underwent MCT during a laparotomy for a deeply located HCC (2.5 cm in diameter) at the border of the anterior and posterior segments of the right hepatic lobe. Two weeks after MCT, he complained of abdominal fullness. Portal vein thrombosis (PVT) was diagnosed because he had massive ascites and an echogenic mass in the portal vein on abdominal ultrasonography. PVT was successfully treated by fibrinolytic therapy with a selective infusion of urokinase via the superior mesenteric artery (SMA). There have been few reports on PVT as a complication of MCT. Attention should be paid to the possible occurrence of PVT as a critical complication after MCT for liver tumors adjacent to the portal vein. Fibrinolytic therapy via the SMA is thus considered to be an effective approach for PVT after MCT.
微波凝固疗法(MCT)是肝细胞癌(HCC)患者的治疗方式之一。一名67岁的肝硬化男性在剖腹手术期间接受了MCT,治疗对象为位于右肝叶前后段交界处的深部肝细胞癌(直径2.5厘米)。MCT两周后,他主诉腹部胀满。因腹部超声显示大量腹水且门静脉内有强回声团块,故诊断为门静脉血栓形成(PVT)。通过经肠系膜上动脉(SMA)选择性输注尿激酶进行纤溶治疗,成功治疗了PVT。关于PVT作为MCT并发症的报道很少。对于门静脉附近肝肿瘤的MCT后,应注意PVT作为严重并发症的可能发生情况。因此,经SMA的纤溶治疗被认为是MCT后PVT的有效治疗方法。